Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-To-Severe Atopic Dermatitis (Vol 14, Pg 983, 2024)
AuthID
P-015-97K
P-015-97K